NGM·Healthcare·$592M·#71 / 520 in Healthcare
SIBN SI-BONE, Inc.
69SOLID
CATEGORY BREAKDOWN
GROWTH32
QUALITY73
STABILITY94
VALUATION90
GOVERNANCE43
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+20.2%
32
> 50% strong
Gross Margin
Revenue retained after direct costs
79.6%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
751 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
20.7%
83
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.9x
90
< 3x strong
Rule of 40
Growth rate plus operating margin
9
34
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.3%
26
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+4.2%
75
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SIBN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SIBN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.